MedTrace Logo

Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)

NCT02829606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-06-20

No results posted yet for this study

Summary

A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and image magnification. The aim of this study is to assess the efficacy of this device on the visual performance of participants suffering from central vision loss, with and without remapping

Conditions

  • Age-related Macular Degeneration

Interventions

OTHER

small scotoma using Head Mounted Display No re-mapping

re-mapping software turned off

OTHER

Large scotoma using Head Mounted Display PLUS re-mapping

re-mapping software turned on

Sponsors & Collaborators

Principal Investigators

  • Erik van Kuijk, MD, PhD · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2023-04-01
Completion
2024-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829606 on ClinicalTrials.gov